Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asymmetric Unit
(-)Asym. Unit - sites
(-)Biological Unit 1
(-)Biol. Unit 1 - sites
(-)Biological Unit 2
collapse expand < >
Image Asymmetric Unit
Asymmetric Unit  (Jmol Viewer)
Image Asym. Unit - sites
Asym. Unit - sites  (Jmol Viewer)
Image Biological Unit 1
Biological Unit 1  (Jmol Viewer)
Image Biol. Unit 1 - sites
Biol. Unit 1 - sites  (Jmol Viewer)
Image Biological Unit 2
Biological Unit 2  (Jmol Viewer)

(-) Description

Title :  STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH THE INHIBITOR 3-((1R)-1-(5-FLUORO-2-METHOXYPHENYL)ETHOXY)-5-(1-METHYL-1H-1,2,3-TRIAZOL-5-YL) PYRIDIN-2-AMINE
 
Authors :  M. A. Mctigue, Y. L. Deng, W. Liu, A. Brooun, A. E. Stewart
Date :  22 Jan 14  (Deposition) - 28 May 14  (Release) - 25 Jun 14  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  1.90
Chains :  Asym. Unit :  A,B
Biol. Unit 1:  A  (1x)
Biol. Unit 2:  B  (1x)
Keywords :  Transferase, Receptor Tyrosine Kinase, Inhibitor (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  T. W. Johnson, P. F. Richardson, S. Bailey, A. Brooun, B. J. Burke, M. R. Collins, J. J. Cui, J. G. Deal, Y. L. Deng, D. M. Dinh, L. D. Engstrom M. He, J. E. Hoffman, R. L. Hoffman, Q. Huang, J. Kath, R. S. Kania, H. Lam J. L. Lam, P. T. Le, L. Lingardo, W. Liu, M. A. Mctigue, C. L. Palmer, N. W. Sach, T. Smeal, G. L. Smith, A. E. Stewart, S. L. Timofeevski, H. Zhu, J. Zhu, H. Y. Zou, M. P. Edwards
Discovery Of (10R)-7-Amino-12-Fluoro-2, 10, 16-Trimethyl-15- Oxo-10, 15, 16, 17-Tetrahydro-2H-8, 4-(Metheno)Pyrazolo[4, 3- H][2, 5, 11]Benzoxadiazacyclotetradecine-3-Carbonitrile (Pf- 06463922), A Macrocyclic Inhibitor Of Alk/Ros1 With Pre- Clinical Brain Exposure And Broad Spectrum Potency Against Alk-Resistant Mutations.
J. Med. Chem. V. 57 4720 2014
PubMed-ID: 24819116  |  Reference-DOI: 10.1021/JM500261Q

(-) Compounds

Molecule 1 - ALK TYROSINE KINASE RECEPTOR
    ChainsA, B
    EC Number2.7.10.1
    EngineeredYES
    Expression SystemSPODOPTERA FRUGIPERDA
    Expression System Cell LineSF9
    Expression System CommonFALL ARMYWORM
    Expression System PlasmidPFASTBAC
    Expression System Taxid7108
    Expression System Vector TypeBACULOVIRUS
    FragmentTYROSINE KINASE DOMAIN, RESIDUES 1093-1411
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    Other DetailsNONPHOSPHORYLATED
    SynonymANAPLASTIC LYMPHOMA KINASE, ANAPLASTIC LYMPHOMA KINASE

 Structural Features

(-) Chains, Units

  12
Asymmetric Unit AB
Biological Unit 1 (1x)A 
Biological Unit 2 (1x) B

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (1, 3)

Asymmetric Unit (1, 3)
No.NameCountTypeFull Name
13U93Ligand/Ion3-[(1R)-1-(5-FLUORO-2-METHOXYPHENYL)ETHOXY]-5-(1-METHYL-1H-1,2,3-TRIAZOL-5-YL)PYRIDIN-2-AMINE
Biological Unit 1 (1, 1)
No.NameCountTypeFull Name
13U91Ligand/Ion3-[(1R)-1-(5-FLUORO-2-METHOXYPHENYL)ETHOXY]-5-(1-METHYL-1H-1,2,3-TRIAZOL-5-YL)PYRIDIN-2-AMINE
Biological Unit 2 (1, 2)
No.NameCountTypeFull Name
13U92Ligand/Ion3-[(1R)-1-(5-FLUORO-2-METHOXYPHENYL)ETHOXY]-5-(1-METHYL-1H-1,2,3-TRIAZOL-5-YL)PYRIDIN-2-AMINE

(-) Sites  (3, 3)

Asymmetric Unit (3, 3)
No.NameEvidenceResiduesDescription
1AC1SOFTWAREHIS B:1124 , VAL B:1130 , ALA B:1148 , LEU B:1196 , GLU B:1197 , MET B:1199 , GLY B:1202 , ARG B:1253 , ASN B:1254 , LEU B:1256 , GLY B:1269 , ASP B:1270BINDING SITE FOR RESIDUE 3U9 B2401
2AC2SOFTWARELEU A:1122 , ALA A:1148 , GLU A:1197 , MET A:1199 , ARG A:1253 , ASN A:1254 , LEU A:1256 , GLY A:1269 , ASP A:1270BINDING SITE FOR RESIDUE 3U9 A2402
3AC3SOFTWAREHOH A:2163 , HOH A:2164 , TYR B:1096 , ASP B:1163 , MET B:1166 , GLU B:1167 , PHE B:1271 , ARG B:1275 , TYR B:1278 , ARG B:1279BINDING SITE FOR RESIDUE 3U9 B2402

(-) SS Bonds  (0, 0)

(no "SS Bond" information available for 4CNH)

(-) Cis Peptide Bonds  (2, 2)

Asymmetric Unit
No.Residues
1Leu A:1190 -Pro A:1191
2Leu B:1190 -Pro B:1191

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (20, 39)

Asymmetric Unit (20, 39)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_041486G1121DALK_HUMANPolymorphism55760835A/BG1121D
02UniProtVAR_063851G1128AALK_HUMANDisease (NBLST3)113994088BG1128A
03UniProtVAR_063852T1151MALK_HUMANDisease (NBLST3)113994091A/BT1151M
04UniProtVAR_063853M1166RALK_HUMANDisease (NBLST3)  ---A/BM1166R
05UniProtVAR_063854I1171NALK_HUMANDisease (NBLST3)  ---A/BI1171N
06UniProtVAR_063855F1174CALK_HUMANDisease (NBLST3)  ---A/BF1174C
07UniProtVAR_063856F1174IALK_HUMANDisease (NBLST3)  ---A/BF1174I
08UniProtVAR_063857F1174LALK_HUMANDisease (NBLST3)863225281A/BF1174L
09UniProtVAR_063858F1174VALK_HUMANDisease (NBLST3)281864719A/BF1174V
10UniProtVAR_063859R1192PALK_HUMANDisease (NBLST3)113994089A/BR1192P
11UniProtVAR_063860A1234TALK_HUMANDisease (NBLST3)  ---A/BA1234T
12UniProtVAR_063861F1245CALK_HUMANDisease (NBLST3)863225283A/BF1245C
13UniProtVAR_063862F1245VALK_HUMANDisease (NBLST3)281864720A/BF1245V
14UniProtVAR_063863I1250TALK_HUMANDisease (NBLST3)113994092A/BI1250T
15UniProtVAR_041487A1274TALK_HUMANPolymorphism45502292A/BA1274T
16UniProtVAR_063864R1275LALK_HUMANUnclassified  ---A/BR1275L
17UniProtVAR_063865R1275QALK_HUMANDisease (NBLST3)113994087A/BR1275Q
18UniProtVAR_063866Y1278SALK_HUMANDisease (NBLST3)863225285A/BY1278S
19UniProtVAR_041488M1328LALK_HUMANPolymorphism56160491A/BM1328L
20UniProtVAR_055987F1376SALK_HUMANPolymorphism17694720A/BF1376S

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 1 (19, 19)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_041486G1121DALK_HUMANPolymorphism55760835AG1121D
03UniProtVAR_063852T1151MALK_HUMANDisease (NBLST3)113994091AT1151M
04UniProtVAR_063853M1166RALK_HUMANDisease (NBLST3)  ---AM1166R
05UniProtVAR_063854I1171NALK_HUMANDisease (NBLST3)  ---AI1171N
06UniProtVAR_063855F1174CALK_HUMANDisease (NBLST3)  ---AF1174C
07UniProtVAR_063856F1174IALK_HUMANDisease (NBLST3)  ---AF1174I
08UniProtVAR_063857F1174LALK_HUMANDisease (NBLST3)863225281AF1174L
09UniProtVAR_063858F1174VALK_HUMANDisease (NBLST3)281864719AF1174V
10UniProtVAR_063859R1192PALK_HUMANDisease (NBLST3)113994089AR1192P
11UniProtVAR_063860A1234TALK_HUMANDisease (NBLST3)  ---AA1234T
12UniProtVAR_063861F1245CALK_HUMANDisease (NBLST3)863225283AF1245C
13UniProtVAR_063862F1245VALK_HUMANDisease (NBLST3)281864720AF1245V
14UniProtVAR_063863I1250TALK_HUMANDisease (NBLST3)113994092AI1250T
15UniProtVAR_041487A1274TALK_HUMANPolymorphism45502292AA1274T
16UniProtVAR_063864R1275LALK_HUMANUnclassified  ---AR1275L
17UniProtVAR_063865R1275QALK_HUMANDisease (NBLST3)113994087AR1275Q
18UniProtVAR_063866Y1278SALK_HUMANDisease (NBLST3)863225285AY1278S
19UniProtVAR_041488M1328LALK_HUMANPolymorphism56160491AM1328L
20UniProtVAR_055987F1376SALK_HUMANPolymorphism17694720AF1376S

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 2 (20, 20)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_041486G1121DALK_HUMANPolymorphism55760835BG1121D
02UniProtVAR_063851G1128AALK_HUMANDisease (NBLST3)113994088BG1128A
03UniProtVAR_063852T1151MALK_HUMANDisease (NBLST3)113994091BT1151M
04UniProtVAR_063853M1166RALK_HUMANDisease (NBLST3)  ---BM1166R
05UniProtVAR_063854I1171NALK_HUMANDisease (NBLST3)  ---BI1171N
06UniProtVAR_063855F1174CALK_HUMANDisease (NBLST3)  ---BF1174C
07UniProtVAR_063856F1174IALK_HUMANDisease (NBLST3)  ---BF1174I
08UniProtVAR_063857F1174LALK_HUMANDisease (NBLST3)863225281BF1174L
09UniProtVAR_063858F1174VALK_HUMANDisease (NBLST3)281864719BF1174V
10UniProtVAR_063859R1192PALK_HUMANDisease (NBLST3)113994089BR1192P
11UniProtVAR_063860A1234TALK_HUMANDisease (NBLST3)  ---BA1234T
12UniProtVAR_063861F1245CALK_HUMANDisease (NBLST3)863225283BF1245C
13UniProtVAR_063862F1245VALK_HUMANDisease (NBLST3)281864720BF1245V
14UniProtVAR_063863I1250TALK_HUMANDisease (NBLST3)113994092BI1250T
15UniProtVAR_041487A1274TALK_HUMANPolymorphism45502292BA1274T
16UniProtVAR_063864R1275LALK_HUMANUnclassified  ---BR1275L
17UniProtVAR_063865R1275QALK_HUMANDisease (NBLST3)113994087BR1275Q
18UniProtVAR_063866Y1278SALK_HUMANDisease (NBLST3)863225285BY1278S
19UniProtVAR_041488M1328LALK_HUMANPolymorphism56160491BM1328L
20UniProtVAR_055987F1376SALK_HUMANPolymorphism17694720BF1376S

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (3, 6)

Asymmetric Unit (3, 6)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PROTEIN_KINASE_ATPPS00107 Protein kinases ATP-binding region signature.ALK_HUMAN1122-1150
 
  2A:1122-1150
B:1122-1150
2PROTEIN_KINASE_TYRPS00109 Tyrosine protein kinases specific active-site signature.ALK_HUMAN1245-1257
 
  2A:1245-1257
B:1245-1257
3RECEPTOR_TYR_KIN_IIPS00239 Receptor tyrosine kinase class II signature.ALK_HUMAN1276-1284
 
  2A:1276-1279
B:1276-1282
Biological Unit 1 (3, 3)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PROTEIN_KINASE_ATPPS00107 Protein kinases ATP-binding region signature.ALK_HUMAN1122-1150
 
  1A:1122-1150
-
2PROTEIN_KINASE_TYRPS00109 Tyrosine protein kinases specific active-site signature.ALK_HUMAN1245-1257
 
  1A:1245-1257
-
3RECEPTOR_TYR_KIN_IIPS00239 Receptor tyrosine kinase class II signature.ALK_HUMAN1276-1284
 
  1A:1276-1279
-
Biological Unit 2 (3, 3)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PROTEIN_KINASE_ATPPS00107 Protein kinases ATP-binding region signature.ALK_HUMAN1122-1150
 
  1-
B:1122-1150
2PROTEIN_KINASE_TYRPS00109 Tyrosine protein kinases specific active-site signature.ALK_HUMAN1245-1257
 
  1-
B:1245-1257
3RECEPTOR_TYR_KIN_IIPS00239 Receptor tyrosine kinase class II signature.ALK_HUMAN1276-1284
 
  1-
B:1276-1282

(-) Exons   (0, 0)

(no "Exon" information available for 4CNH)

(-) Sequences/Alignments

Asymmetric Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:286
 aligned with ALK_HUMAN | Q9UM73 from UniProtKB/Swiss-Prot  Length:1620

    Alignment length:309
                                  1103      1113      1123      1133      1143      1153      1163      1173      1183      1193      1203      1213      1223      1233      1243      1253      1263      1273      1283      1293      1303      1313      1323      1333      1343      1353      1363      1373      1383      1393         
           ALK_HUMAN   1094 PNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYG 1402
               SCOP domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..ee....eehhhhh...hhh.eeeeee.------.eeeeee.-------.eeeeeee.....hhhhhhhhhhhhhhhhhh.......eeeee......eeeee....eehhhhhhhh..........hhhhhhhhhhhhhhhhhhhhhh.......hhh.eee........eee..hhhhhhhhh----------..hhhhhhhhhhhh...hhhhhhhhhhhhhhhhhh.........hhhhhhhhhhh..........hhhhhhhhhhhh..hhhhh.hhhhhhhhhhhhhhhhhhhh........ Sec.struct. author
             SAPs(SNPs) (1) ---------------------------D-----------------------------M--------------R----N--C-----------------P-----------------------------------------T----------C----T-----------------------TL--S-------------------------------------------------L-----------------------------------------------S-------------------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) --------------------------------------------------------------------------------I----------------------------------------------------------------------V-----------------------------Q------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) --------------------------------------------------------------------------------L------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ SAPs(SNPs) (3)
             SAPs(SNPs) (4) --------------------------------------------------------------------------------V------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ SAPs(SNPs) (4)
                    PROSITE ----------------------------PROTEIN_KINASE_ATP           ----------------------------------------------------------------------------------------------PROTEIN_KINAS------------------RECEPTOR_---------------------------------------------------------------------------------------------------------------------- PROSITE
                 Transcript --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript
                4cnh A 1094 PNYCFAGKTSSISDLKEVPRKNITLIRGL------EVYEGQVS-------PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR----------MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYG 1402
                                  1103      1113        |-     |1133  |      -|     1153      1163      1173      1183      1193      1203      1213      1223      1233      1243      1253      1263      1273     |   -      1293      1303      1313      1323      1333      1343      1353      1363      1373      1383      1393         
                                                     1122   1129   1136    1144                                                                                                                                   1279       1290                                                                                                                

Chain B from PDB  Type:PROTEIN  Length:294
 aligned with ALK_HUMAN | Q9UM73 from UniProtKB/Swiss-Prot  Length:1620

    Alignment length:309
                                  1102      1112      1122      1132      1142      1152      1162      1172      1182      1192      1202      1212      1222      1232      1242      1252      1262      1272      1282      1292      1302      1312      1322      1332      1342      1352      1362      1372      1382      1392         
           ALK_HUMAN   1093 NPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEY 1401
               SCOP domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..eeee..eeee.hhh...hhh.eeeeeeeee....eeeeeee.-------.eeeeeee.....hhhhhhhhhhhhhhhhhh.......eeeee......eeeee....eehhhhhhhh.....---..hhhhhhhhhhhhhhhhhhhhhh.......hhh.eee........eee....hhhhhhhh..-----....hhhhhhhhhhhhh..hhhhhhhhhhhhhhhhhh.........hhhhhhhhhhh..........hhhhhhhhhhhh..hhhhh.hhhhhhhhhhhhhhhhhhhh....... Sec.struct. author
             SAPs(SNPs) (1) ----------------------------D------A----------------------M--------------R----N--C-----------------P-----------------------------------------T----------C----T-----------------------TL--S-------------------------------------------------L-----------------------------------------------S------------------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ---------------------------------------------------------------------------------I----------------------------------------------------------------------V-----------------------------Q------------------------------------------------------------------------------------------------------------------------------ SAPs(SNPs) (2)
             SAPs(SNPs) (3) ---------------------------------------------------------------------------------L----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (3)
             SAPs(SNPs) (4) ---------------------------------------------------------------------------------V----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (4)
                    PROSITE -----------------------------PROTEIN_KINASE_ATP           ----------------------------------------------------------------------------------------------PROTEIN_KINAS------------------RECEPTOR_--------------------------------------------------------------------------------------------------------------------- PROSITE
                 Transcript --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript
                4cnh B 1093 NPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVS-------PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPS---SLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY-----CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEY 1401
                                  1102      1112      1122      1132   |     - |    1152      1162      1172      1182      1192      1202      1212   |  1222      1232      1242      1252      1262      1272      1282     |1292      1302      1312      1322      1332      1342      1352      1362      1372      1382      1392         
                                                                    1136    1144                                                                    1216   |                                                          1282  1288                                                                                                                 
                                                                                                                                                        1220                                                                                                                                                                                     

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (0, 0)

(no "SCOP Domain" information available for 4CNH)

(-) CATH Domains  (0, 0)

(no "CATH Domain" information available for 4CNH)

(-) Pfam Domains  (0, 0)

(no "Pfam Domain" information available for 4CNH)

(-) Gene Ontology  (30, 30)

Asymmetric Unit(hide GO term definitions)
Chain A,B   (ALK_HUMAN | Q9UM73)
molecular function
    GO:0005524    ATP binding    Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
    GO:0004704    NF-kappaB-inducing kinase activity    Catalysis of the phosphorylation of the alpha or beta subunit of the inhibitor of kappaB kinase complex (IKK).
    GO:0042802    identical protein binding    Interacting selectively and non-covalently with an identical protein or proteins.
    GO:0016301    kinase activity    Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
    GO:0000166    nucleotide binding    Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0004672    protein kinase activity    Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
    GO:0004713    protein tyrosine kinase activity    Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
    GO:0016740    transferase activity    Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.
    GO:0004714    transmembrane receptor protein tyrosine kinase activity    Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate.
biological process
    GO:0038061    NIK/NF-kappaB signaling    The process in which a signal is passed on to downstream components within the cell through the NIK-dependent processing and activation of NF-KappaB. Begins with activation of the NF-KappaB-inducing kinase (NIK), which in turn phosphorylates and activates IkappaB kinase alpha (IKKalpha). IKKalpha phosphorylates the NF-Kappa B2 protein (p100) leading to p100 processing and release of an active NF-KappaB (p52).
    GO:0000187    activation of MAPK activity    The initiation of the activity of the inactive enzyme MAP kinase (MAPK).
    GO:0008283    cell proliferation    The multiplication or reproduction of cells, resulting in the expansion of a cell population.
    GO:0007399    nervous system development    The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
    GO:0048666    neuron development    The process whose specific outcome is the progression of a neuron over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell.
    GO:0018108    peptidyl-tyrosine phosphorylation    The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
    GO:0016310    phosphorylation    The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
    GO:0051092    positive regulation of NF-kappaB transcription factor activity    Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB.
    GO:0046777    protein autophosphorylation    The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
    GO:0006468    protein phosphorylation    The process of introducing a phosphate group on to a protein.
    GO:0042981    regulation of apoptotic process    Any process that modulates the occurrence or rate of cell death by apoptotic process.
    GO:0007165    signal transduction    The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
    GO:0007169    transmembrane receptor protein tyrosine kinase signaling pathway    A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell where the receptor possesses tyrosine kinase activity, and ending with regulation of a downstream cellular process, e.g. transcription.
cellular component
    GO:0070062    extracellular exosome    A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
    GO:0016021    integral component of membrane    The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0005887    integral component of plasma membrane    The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0005622    intracellular    The living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
    GO:0043234    protein complex    A stable macromolecular complex composed (only) of two or more polypeptide subunits along with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-protein prosthetic groups (such as nucleotides or metal ions). Prosthetic group in this context refers to a tightly bound cofactor. The component polypeptide subunits may be identical.

 Visualization

(-) Interactive Views

Asymmetric Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    3U9  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    Leu A:1190 - Pro A:1191   [ RasMol ]  
    Leu B:1190 - Pro B:1191   [ RasMol ]  
 
Biological Units
  Complete Structure
    Biological Unit 1  [ Jena3D ]
    Biological Unit 2  [ Jena3D ]

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  4cnh
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  ALK_HUMAN | Q9UM73
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  2.7.10.1
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  613014
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  ALK_HUMAN | Q9UM73
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        ALK_HUMAN | Q9UM732kup 2kuq 2xb7 2xba 2xp2 2yfx 2yhv 2yjr 2yjs 2ys5 2yt2 3aox 3l9p 3lcs 3lct 4anl 4anq 4ans 4ccb 4ccu 4cd0 4cli 4clj 4cmo 4cmt 4cmu 4ctb 4ctc 4dce 4fnw 4fnx 4fny 4fnz 4fob 4foc 4fod 4joa 4mkc 4tt7 4z55 5a9u 5aa8 5aa9 5aaa 5aab 5aac 5fto 5ftq 5imx 5iug 5iuh 5iui 5j7h 5kz0

(-) Related Entries Specified in the PDB File

4cmo STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH THE INHIBITOR 2-((1R)-1-((3-AMINO-6-( 2-METHOXYPYRIDIN-3-YL)PYRAZIN-2-YL)OXY)ETHYL)-4- FLUORO-N-METHYLBENZAMIDE
4cmt STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH THE INHIBITOR 3-((1R)-1-(5-FLUORO-2-( 2H-1,2,3-TRIAZOL-2-YL)PHENYL)ETHOXY)-5-(3-( METHYLSULFONYL)PHENYL)PYRIDIN-2-AMINE
4cmu STRUCTURE OF THE HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH THE INHIBITOR (10R)-7-AMINO-12-FLUORO-1 ,3,10,16-TETRAMETHYL-16,17-DIHYDRO-1H-8,4-( METHENO)PYRAZOLO(4,3-H)(2,5,11) BENZOXADIAZACYCLOTETRADECIN-15(10H)-ONE